ISS/SIC
Journal (WJS)
Congress
Create Account
Login
International Society of Surgery (ISS)
Société Internationale de Chirurgie (SIC)
Integrated Societies: IATSIC | IASMEN | BSI | ISDS
‘ONCOPLASTY – THINK BEYOND MALIGNANCY’- ADOPTING ONCOPLASTIC BREAST SURGERY(OBS) PRINCIPLES FOR THE SURGICAL MANAGEMENT OF IDIOPATHIC GRANULOMATOUS MASTITIS(IGM)
megu92@gmail.com
 
Back
Slot ID
Abstract Title
‘ONCOPLASTY – THINK BEYOND MALIGNANCY’- ADOPTING ONCOPLASTIC BREAST SURGERY(OBS) PRINCIPLES FOR THE SURGICAL MANAGEMENT OF IDIOPATHIC GRANULOMATOUS MASTITIS(IGM)
Author Details
No. of Authors
4
Including the presenting author
Author 1
Meghana Shetty megu92@gmail.com King George's Medical University, Lucknow, Uttar Pradesh Endocrine and Breast Surgery Lucknow India *
Author 2
Kul Ranjan Singh kulranjan@hotmail.com King George's Medical University, Lucknow, Uttar Pradesh Endocrine and Breast Surgery Lucknow India
Author 3
Pooja Ramakant poojaramakant@gmail.com King George's Medical University, Lucknow, Uttar Pradesh Endocrine and Breast Surgery Lucknow India
Author 4
Anand Mishra mishra101@gmail.com Lucknow Endocrine and Breast Surgery Lucknow India
Author 5
Author 6
Author 7
Author 8
Author 9
Author 10
Author 11
Author 12
Presenting Author Name
Meghana Shetty
Presenting Author Email
megu92@gmail.com
Presenting Author Country
India
Abstract
Abstract type
Oral or Poster
Introduction *
IGM, a chronic inflammatory condition resembling breast cancer, causes diagnostic challenges for surgeons. Ambiguous pathophysiology, no consensus on management and high recurrence underscore its severity. We applied OBS principles for surgical management of IGM to study its effects on symptom resolution, recurrence, complications and cosmesis.
Material & Method *
In this ambispective study, all patients diagnosed with IGM received tapering doses of oral steroids (OS). Patients with partial/no response or progression with OS were planned for surgery. Based on size of residual disease, were divided into two groups. Study group was patients who underwent WLE + OBS and comparator group- who underwent WLE only. Symptom resolution, recurrence rates, complication rates and patient-reported outcomes concerning breast shape, symmetry, and scars(using standardized questionnaire) were assessed in both groups.
Results *
142 patients included; 37 resolved with OS, 105 underwent surgery. 49.5% (n=52) with large, skin-involved, multiquadrant tumours underwent level I/II OBS, while 50.5% (n=53) with smaller, single-quadrant tumours had WLE. 17 had recurrence in the 18-month follow-up period. OBS group had statistically significantly lower recurrence rate, ie n= 3(p< 0.006). Better outcomes in appearance, symmetry, and scars observed with OBS group despite larger volume of excision without an increase in complication rates. Our oncoplastic techniques included a plethora of dermoglandular, perforator, transposition and latissimus dorsi flaps.
Conclusion *
Applying oncoplastic principles to surgically manage IGM- an often disfiguring benign breast disease gives breast surgeons the liberty to excise wider margins without compromising on the breast appearance, leading to low recurrence rates, simultaneously providing excellent patient-related outcomes.
File Upload #1
https://storage.unitedwebnetwork.com/files/1258/66c3f5c57ab5460901a222a5bc758be5.png
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
File Upload #2
https://storage.unitedwebnetwork.com/files/1258/37c2e68b2e7cfe39cfa6bd0bddbb72e9.png
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
Select Main Category
5 Breast Surgery organized by BSI
Select Sub Category
5.03 Breast Disease-Miscellaneous
Submission Status
Withdrawn
Word counter
246
Abstract Prizes
Eligible for the BSI Free Paper Prize
Yes
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
Eligible for the Grassi Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Eligible for the Kitajima Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Vimeo Link